In addition, it was observed that the abundant intracellular kynurenine in cell lines were driven by either IDO1 or TDO or both being simultaneously expressed suggesting that cancer cells can probably use either enzyme or potentially both to produce kynurenine and its downstream metabolites19. The gene discussed is IDO1; the disease is cancer.